Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Fig 3

Research Article

Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with 18F-Fluorodeoxyglucose MicroPET

Figure 3

(a) 18FDG-PET images of activity of cerebral ischemic regions of the glucose metabolism. Sham group (sham), cerebral ischemia-reperfusion untreated group (CIRU), scutellarin 50 mg/Kg group (Scu-50), scutellarin 25 mg/Kg group (Scu-25), and nimodipine 10 mg/Kg group (nimodipine) in days 0, 7, 14, 21, and 28 respectively. (b) Ratios of cortex to cerebellum in different regions in the brain of the glucose metabolism sham group (sham), cerebral ischemia-reperfusion untreated group (CIRU), scutellarin 50 mg/Kg group (Scu-50), scutellarin 25 mg/Kg group (Scu-25), and nimodipine 10 mg/Kg group (nimodipine) in days 0, 7, 14, 21, and 28, respectively.
507091.fig.003a
(a)
507091.fig.003b
(b)

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.